Regulatory T cells in rheumatoid arthritis

Current Rheumatology Reports

Volumn 10, Issue 5, 2008, Pages 405-412

  Sarkar, Sujata ^a   Fox, David A ^a  

^a Division of Rheumatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 7; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 17;

ANTIGEN EXPRESSION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL THERAPY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; GENE MUTATION; IMMUNE DYSREGULATION; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; AUTOIMMUNITY; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-17; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 55949101372     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-008-0065-y     Document Type: Review

References (84)

1. Gershon RK, Kondo K: Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970, 18: 723-737.
2. Sakaguchi S, Sakaguchi N, Asano M, et al.: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155: 1151-1164.
3. Asano M, Toda M, Sakaguchi N, Sakaguchi S: Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996, 184: 387-396.
4. Itoh M, Takahashi T, Sakaguchi N, et al.: Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999, 162: 5317-5326.
5. Suri-Payer E, Amar A, McHugh R, et al.: Post-thymectomy autoimmune gastritis: Fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur J Immunol 1999, 29: 669-677.
6. Schorle H, Holtschke T, Huenig T, et al.: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991, 352: 621-624.
7. Setoguchi R, Hori S, Takahashi T, Sakaguchi S: Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005, 201: 723-735.
8. Suzuki H, Zhou YW, Kato M, et al.: Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo. J Exp Med 1999, 190: 1561-1572.
9. Malek TR, Yu A, Vincek V, et al.: CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002, 17: 167-178.
10. Takahashi T, Kuniyasu Y, Toda M, et al.: Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998, 10: 1969-1980.
11. Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998, 188: 287-296.
12. Brunkow ME, Jeffery, E, Hjerrild, KA, et al.: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27: 68-73.
13. Chatila TA, Blaeser F, Ho N, et al.: JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000, 106: R75-R81.
14. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299: 1057-1061.
15. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4: 330-336.
16. Yagi H, Nomura T, Nakamura K, et al.: Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004, 16: 1643-1656.
17. Oswald-Richter K, Grill SM, Shariat N, et al.: HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2004, 2: 955-966.
18. Fontenot J, Rasmussen J, Williams L, et al.: Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005, 22: 329-341.
19. von Boehmer H: Mechanisms of suppression by suppressor T cells. Nat Immunol 2005, 6: 338-344.
20. Williams LM, Rudensky AY: Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007, 8: 277-284.
21. Zheng Y, Josefowicz SZ, Kas A, et al.: Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445: 936-940.
22. Marson A, Kretschmer K, Frampton GM, et al.: Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007, 445: 931-935.
23. Wu Y, Borde M, Heissmeyer V, et al.: FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006, 126: 375-387.
24. Ono M, Yaguchi H, Ohkura N, et al.: Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007, 446: 685-689.
25. Pacholczyk R, Kern J, Singh N, et al.: Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity 2007, 27: 493-504.
26. Zheng SG, Gray JD, Ohtsuka K, et al.: Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25-precursors. J Immunol 2002, 169: 4183-4189.
27. Zheng SG, Wang J, Wang P, et al.: IL-2 is essential for TGF-beta to convert naive CD4+CD25-cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 2007, 178: 2018-2027.
28. Apostolou I, von Boehmer H: In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004, 199: 1401-1408.
29. Kretschmer K, Apostolou I, Hawiger D, et al.: Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005, 6: 1219-1227.
30. O'Garra A, Vieira P: Regulatory T cells and mechanisms of immune system control. Nat Med 2004, 10: 801-805.
31. Vieira PL, Christensen JR, Minaee S, et al.: IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 2004, 172: 5986-5993.
32. Mills KH, McGuirk P: Antigen-specific regulatory T cells-their induction and role in infection. Semin Immunol 2004, 16: 107-117.
33. Kemper C, Chan AC, Green JM, et al.: Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421: 388-392.
34. Cosmi L, Liotta F, Lazzeri E, et al.: Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 2003, 102: 4107-4114.
35. Rifa'i M, Kawamoto Y, Nakashima I, Suzuki H: Essential roles of CD8+ CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 2004, 200: 1123-1134.
36. Endharti AT, Rifa'I M, Shi Z, et al.: Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 2005, 175: 7093-7097.
37. Vlad G, CorBesini R, Suciu-Foca N: License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol 2005, 174: 5907-5914.
38. Fischer K, Voelkl S, Heymann J, et al.: Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8-double-negative regulatory T cells. Blood 2005, 105: 2828-2835.
39. Bluestone JA, Abbas AK: Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003, 3: 253-257.
40. Paust S, Lu L, McCarty N, Cantor H: Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 2004, 101: 10398-10403.
41. Mellor AL, Munn DH: IDO expreTsion by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004, 4: 762-774.
42. Perez N, Karumuthil-Melethil S, Li R, et al.: Preferential costimulation by CD80 results in IL-10-dependent TGFbeta1(+)-adaptive regulatory T cell generation. J Immunol 2008, 180: 6566-6576.
43. Liang B, Workman C, Lee J, et al.: Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 2008, 180: 5916-5926.
44. Grossman WJ, Verbsky JW, Barchet W, et al.: Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004, 21: 589-601.
45. Deaglio S, Dwyer KM, Gao W, et al.: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007, 204: 1257-1265.
46. Collison LW, Workman CJ, Kuo TT, et al.: The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450: 566-569.
47. Tesmer LA, Lundy SK, Sarkar S, Fox DA: Th17 cells in human disease. Imm Reviews 2008, 223: 87-113.
48. Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299: 1033-1036.
49. van Mierlo GJ, Scherer HU, Hameetman M: Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators. J Immunol 2008, 180: 2747-2751.
50. Lohr J, Knoechel B, Wang JJ, et al.: Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 2006, 203: 2785-2791.
51. Morgan ME, Sutmuller RP, Witteveen HJ, et al.: CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003, 48: 1452-1460.
52. Morgan ME, Flierman R, van Duivenvoorde LM, et al.: Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005, 52: 2212-2221.
53. Frey O, Petrow PK, Gajda M, et al.: The role of regulatory T cells in antigen-induced arthritis: Aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 2005, 7: R291-R301.
54. Nguyen LT, Jacobs J, Mathis D, Benoist C: Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 2007, 56: 509-520.
55. Zaiss MM, Axmann R, Zwerina J, et al.: Treg cells suppress osteoclast formation: A new link between the immune system and bone. Arthritis Rheum 2007, 56: 4104-4112.
56. Kelchtermans H, De Klerck B, Mitera T, et al.: Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: An important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res Ther 2005, 7: R402-R415.
57. Ohata J, Miura T, Johnson TA, et al.: Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts. Arthritis Rheum 2007, 56: 2947-2956.
58. van Amelsfort JM, van Roon JA, Noordegraaf M, et al.: Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 2007, 56: 732-742.
59. Ehrenstein MR, Evans JG, Singh A, et al.: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004, 200: 277-285.
60. Cao D, van Vollenhoven R, Klareskog L, et al.: CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004, 6: R335-R346.
61. Möttönen M, Heikkinen J, Mustonen L, et al.: CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005, 140: 360-367.
62. Lawson CA, Brown AK, Bejarano V, et al.: Early rheumatoid arthritis is associated with a deficit in the CD4+CD25 high regulatory T cell population in peripheral blood. Rheumatology (Oxford) 2006, 45: 1210-1217.
63. van Amelsfort JM, Jacobs KM, Bijlsma JW, et al.: CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004, 50: 2775-2785.
64. Liu MF, Wang CR, Fung LL, et al.: The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand J Immunol 2005, 62: 312-317.
65. Behrens F, Himsel A, Rehart S, et al.: Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis. Ann Rheum Dis, 2007, 66: 1151-1156.
66. Cao D, Malmström V, Baecher-Allan C, et al.: Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003, 33: 215-223.
67. Jiao Z, Wang W, Jia R, et al.: Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol 2007, 36: 428-433.
68. Cao D, Böjesson O, Larsson P, et al.: FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints. Scand J Immunol 2006, 63: 444-452.
69. Valencia X, Stephens G, Goldbach-Mansky R, et al.: TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006, 108: 253-261.
70. Goldstein I, Ben-Horin S, Koltakov A, et al.: Alpha1beta1 Integrin+ and regulatory Foxp3+ T cells constitute two functionally distinct human CD4+ T cell subsets oppositely modulated by TNFalpha blockade. J Immunol 2007, 178: 201-210.
71. Nadkarni S, Mauri C, Ehrenstein MR: Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 2007, 204: 33-39.
72. Bresson D, Togher L, Rodrigo E, et al.: Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J Clin Invest 2006, 116: 1371-1381.
73. Deepe GS Jr, Gibbons RS: TNF-alpha antagonism generates a population of antigen-specific CD4+CD25+ T cells that inhibit protective immunity in murine histoplasmosis. J Immunol 2008, 180: 1088-1097.
74. Guichelaar T, ten Brink CB, van Kooten PJ, et al.: Autoantigen-specific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response. J Immunol 2008, 180: 1373-1381.
75. Finnegan A, Kaplan CD, Cao Y, et al.: Collagen-induced arthritis is exacerbated in IL-10-deficient mice. Arthritis Res Ther 2003, 5: R18-R24.
76. McGeachy MJ, Bak-Jensen KS, Chen Y, et al.: TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007, 8: 1390-1397.
77. Yudoh K, Matsuno H, Nakazawa F, et al.: Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum 2000, 43: 617-627.
78. Katsikis PD, Chu CQ, Brennan FM, et al.: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994, 179: 1517-1527.
79. Cush JJ, Splawski JB, Thomas R, et al.: Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995, 38: 96-104.
80. van Bilsen JH, van Dongen H, Lard LR, et al.: Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis. Proc Natl Acad Sci U S A 2004, 101: 17180-17185.
81. Peluso I, Fantini MC, Fina D, et al.: IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 2007, 178: 732-739.
82. Li J, Shen W, Kong K, Liu Z: Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis. Scand J Immunol 2006, 64: 515-522.
83. Walker MR, Kasprowicz DJ, Gersuk VH, et al.: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest 2003, 112: 1437-1443.
84. Roncarolo MG, Battaglia M: Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007, 7: 585-598.